COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator (Q82931755)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Jun Yu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Emilia Ip

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Aileen Dela Peña

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jing Yun Hou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jayshree Sesha

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Natasha Pera

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Pauline Hall

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Richard Kirsch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Isabelle Leclercq

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Geoffrey C Farrell

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

826-836

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury

18 January 2020

cites work

1 reference

7 January 2021

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

7 January 2021

Pathogenesis of steatohepatitis

1 reference

7 January 2021

In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases

1 reference

7 January 2021

CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis

1 reference

7 January 2021

4-hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression

1 reference

7 January 2021

Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression

1 reference

7 January 2021

Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice

1 reference

7 January 2021

Leptin is essential for the hepatic fibrogenic response to chronic liver injury

1 reference

7 January 2021

Prostaglandins and leukotrienes: advances in eicosanoid biology

1 reference

7 January 2021

Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

1 reference

7 January 2021

Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide

1 reference

7 January 2021

Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells

1 reference

7 January 2021

Characterization of human cyclooxygenase 2 gene promoter localization of a TGF-beta response element.

1 reference

7 January 2021

Nonalcoholic steatohepatitis

1 reference

7 January 2021

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

7 January 2021

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

1 reference

7 January 2021

Etiopathogenesis of nonalcoholic steatohepatitis

1 reference

7 January 2021

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

1 reference

7 January 2021

Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat.

1 reference

7 January 2021

Peroxisome proliferator-activated receptor alpha target genes

1 reference

7 January 2021

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction

1 reference

7 January 2021

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

1 reference

7 January 2021

Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice

1 reference

7 January 2021

Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice

1 reference

7 January 2021

Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice

1 reference

7 January 2021

The PPARalpha-leukotriene B4 pathway to inflammation control.

1 reference

7 January 2021

Peroxisome Proliferator-activated Receptor α Activation Modulates Cellular Redox Status, Represses Nuclear Factor-κB Signaling, and Reduces Inflammatory Cytokine Production in Aging

1 reference

7 January 2021

Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells.

1 reference

7 January 2021

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

1 reference

7 January 2021

Rodent nutritional model of non‐alcoholic steatohepatitis: Species, strain and sex difference studies

1 reference

7 January 2021

Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation

1 reference

7 January 2021

NASH--hepatic metabolism and not simply the metabolic syndrome

1 reference

7 January 2021

NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis

1 reference

7 January 2021

Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes

1 reference

7 January 2021

Cyclooxygenase-2 gene disruption attenuates the severity of acute pancreatitis and pancreatitis-associated lung injury

1 reference

7 January 2021

Mouse liver cell culture. I. Hepatocyte isolation

1 reference

7 January 2021

Hepatic ischemic preconditioning in mice is associated with activation of NF-kappaB, p38 kinase, and cell cycle entry

1 reference

7 January 2021

Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis.

1 reference

7 January 2021

Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta

1 reference

7 January 2021

Activators and target genes of Rel/NF-kappaB transcription factors

1 reference

7 January 2021

Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element

1 reference

7 January 2021

Chemoprevention of gastric cancer by celecoxib in rats.

1 reference

7 January 2021

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

7 January 2021

Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin

1 reference

7 January 2021

Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16557554%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference